China's Pharma Senior Industry Members Comment On New GMP Guidelines
This article was originally published in PharmAsia News
Executive Summary
Two-thirds of 4,800 drug makers in China will need large investments in upgrading their facilities to meet the sterility requirements of the new GMP guidelines, said Wu Changhai, general manager of Guangzhou Pharmaceutical